top of page
The latest from NuvOx
Search
Health Canada Allows Phase IIa Clinical Trial in COVID-19 Patients with Respiratory Failure
Health Canada allows a Phase IIa Trial in COVID-19 patients with Respiratory Failure
Jun 29, 2020
NuvOx Expands Production Line
NuvOx Pharma is breaking ground on an addition to its manufacturing facility. Read full story
Dec 7, 2019
NuvOx Pharma’s NanO2 Shows Positive Results in Phase Ib/II Stroke Trial
Positive results of NuvOx Pharma’s NanO2 (DDFPe) in the treatment of stroke have been published at the International Stroke Conference. A...
Feb 28, 2019
NuvOx Wins TechConnect Defense Innovation Award
NuvOx was awarded the TechConnect Defense Innovation Award based on the potential impact the technology will have on national security.
Oct 18, 2017
NuvOx Pharma wins AZBio Fast Lane Award
NuvOx was honored with the AZBIO Fast Lane Award for the company's many achievements in the last 18 months.
Oct 11, 2017
National Cancer Institute Grants $3M to NuvOx Pharma for Phase II Clinical Trial in Brain Cancer
The NCI Grants $3M to NuvOx for a Phase II clinical trial in the brain cancer, glioblastoma.
Sep 29, 2017
NuvOx Wins MedCity INVEST Perfect Pitch Contest
NuvOx Pharma wins 1st place out of the biopharma companies at the MedCity INVEST Perfect Pitch Contest.
May 19, 2017
NuvOx wins Venture Madness competition and $60,000 prize.
NuvOx wins 1st place out of 113 entrants and a $60,000 cash prize.
Mar 4, 2016
bottom of page